M. Scott Harris
2021
In 2021, M. Scott Harris earned a total compensation of $2.3M as Chief Medical Officer at PharmAthene, a 238% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,680 |
|---|---|
| Option Awards | $1,237,015 |
| Salary | $444,385 |
| Stock Awards | $412,135 |
| Other | $4,046 |
| Total | $2,263,260 |
Harris received $1.2M in option awards, accounting for 55% of the total pay in 2021.
Harris also received $165.7K in non-equity incentive plan, $444.4K in salary, $412.1K in stock awards and $4K in other compensation.
Rankings
In 2021, M. Scott Harris' compensation ranked 5,551st out of 12,415 executives tracked by ExecPay. In other words, Harris earned more than 55.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,551 out of 12,415 | 55th |
Division Manufacturing | 2,347 out of 5,508 | 57th |
Major group Chemicals And Allied Products | 1,019 out of 2,378 | 57th |
Industry group Drugs | 908 out of 2,099 | 57th |
Industry Pharmaceutical Preparations | 653 out of 1,549 | 58th |
Source: SEC filing on August 16, 2022.
Harris' colleagues
We found four more compensation records of executives who worked with M. Scott Harris at PharmAthene in 2021.